✨ Your Portfolio is fetched and updated from zerodha.
Nano Hospitals

Dr Lalchandani Labs Ltd.

DLCL

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹10 Cr.
P/E
23.23

Dr Lalchandani Labs Ltd.

  • Dr Lalchandani Labs
  • Clinitech Laboratory
  • DhanvantriJeevan Rek

FAQs on Dr Lalchandani Labs Ltd. Shareprice

Dr Lalchandani Labs has given better returns compared to its competitors.
Dr Lalchandani Labs has grown at ~21.2% over the last 1yrs while peers have grown at a median rate of -37.41%

Dr Lalchandani Labs is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Dr Lalchandani Labs is 23.23, while 3 year average PE is 11.83.
Also latest EV/EBITDA of Dr Lalchandani Labs is 0 while 3yr average is 13.75.

View FAQ's On Business

Growth Table

  • Dr Lalchandani Labs Ltd.
  • Clinitech Laboratory
  • DhanvantriJeevan Rek

Balance Sheet

  • Dr Lalchandani Labs Ltd.
  • Clinitech Laboratory
  • DhanvantriJeevan Rek

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Dr Lalchandani Labs Ltd.
  • Clinitech Laboratory
  • DhanvantriJeevan Rek

Cash Flow

  • Dr Lalchandani Labs Ltd.
  • Clinitech Laboratory
  • DhanvantriJeevan Rek

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Dr Lalchandani Labs Ltd.
  • Clinitech Laboratory
  • DhanvantriJeevan Rek

Quarterly Results

  • Dr Lalchandani Labs Ltd.
  • Clinitech Laboratory
  • DhanvantriJeevan Rek

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Dr Lalchandani Labs Ltd. Financials

Balance sheet of Dr Lalchandani Labs is moderately strong.

The net debt of Dr Lalchandani Labs is decreasing.
Latest net debt of Dr Lalchandani Labs is ₹0.77 Crs as of Mar-25.
This is less than Mar-24 when it was ₹1.28 Crs.

The profit is oscillating.
The profit of Dr Lalchandani Labs is ₹0.62 Crs for Mar 2024, -₹1.56 Crs for Mar 2023 and ₹0.93 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Dr Lalchandani Labs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech